These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 2319513

  • 1. In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
    Sanders CV, Aldridge KE.
    J Reprod Med; 1990 Mar; 35(3 Suppl):313-6. PubMed ID: 2319513
    [Abstract] [Full Text] [Related]

  • 2. Implications of beta-lactamase-inhibitor combinations.
    Fuchs PC, Barry AL.
    J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
    [Abstract] [Full Text] [Related]

  • 3. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

  • 4. Ampicillin-sulbactam and ticarcillin-clavulanic acid: a comparison of their in vitro activity and review of their clinical efficacy.
    Itokazu GS, Danziger LH.
    Pharmacotherapy; 1991 Feb; 11(5):382-414. PubMed ID: 1745624
    [Abstract] [Full Text] [Related]

  • 5. [Comparative bacteriostatic activity of ticarcillin, alone and combined with clavulanic acid, 5 cephalosporins and metronidazole against 100 strains of Bacteroides fragilis].
    de Barbeyrac B, Quentin C, Bebear C.
    Pathol Biol (Paris); 1984 May; 32(5):433-5. PubMed ID: 6739151
    [Abstract] [Full Text] [Related]

  • 6. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units.
    Gill CJ, Ponticas S, Shungu DL, Guerriero S.
    Clin Ther; 1991 May; 13(1):25-37. PubMed ID: 2029725
    [Abstract] [Full Text] [Related]

  • 7. Development of beta-lactamase inhibitors.
    Sutherland R.
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [Abstract] [Full Text] [Related]

  • 8. Newer beta-lactam agents and the Bacteroides fragilis group.
    Cuchural GJ.
    Pharmacotherapy; 1991 Mar; 11(2 ( Pt 2)):51S-55S. PubMed ID: 2041832
    [Abstract] [Full Text] [Related]

  • 9. Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
    Downes J, Andrew JH.
    Pathology; 1988 Jul; 20(3):260-3. PubMed ID: 3205597
    [Abstract] [Full Text] [Related]

  • 10. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
    Jacobs MR, Spangler SK, Appelbaum PC.
    J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
    [Abstract] [Full Text] [Related]

  • 11. [In vitro activity of the combination ticarcillin-clavulanic acid on bacterial isolates in surgery].
    Branger C, Kitzis M, Le Mée J.
    Pathol Biol (Paris); 1986 Apr; 34(4):245-8. PubMed ID: 3528998
    [Abstract] [Full Text] [Related]

  • 12. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S, Hanaki H, Nagayama A.
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [Abstract] [Full Text] [Related]

  • 13. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L, Castello L, Di Martino A, Greco G, Legaria MC, Litterio M, Predari SC, Rollet R, Rossetti A, Carloni G, Sarchi MI, Bianchini H.
    Rev Argent Microbiol; 2007 Apr; 39(3):156-60. PubMed ID: 17987852
    [Abstract] [Full Text] [Related]

  • 14. Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children.
    Citron DM, Goldstein EJ, Kenner MA, Burnham LB, Inderlied CB.
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S356-60. PubMed ID: 7548597
    [Abstract] [Full Text] [Related]

  • 15. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
    Bourgault AM, Lamothe F.
    J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324
    [Abstract] [Full Text] [Related]

  • 16. In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.
    Barry AL, Jones RN, Packer RR.
    J Antimicrob Chemother; 1986 Jan; 17(1):125-7. PubMed ID: 3005222
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa.
    Klepser ME, Marangos MN, Zhu Z, Nicolau DP, Quintiliani R, Nightingale CH.
    Antimicrob Agents Chemother; 1997 Feb; 41(2):435-9. PubMed ID: 9021203
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis.
    Martin MA, Liebana J, Castillo AM, Gutierrez J, Piédrola G.
    Microbios; 1991 Feb; 67(272-273):195-202. PubMed ID: 1779879
    [Abstract] [Full Text] [Related]

  • 19. Augmentation effect of clavulanic acid with penicillin, cephalothin and ticarcillin against Bacteroides fragilis.
    Bansal MB, Chuah SK, Oryema-Lalobo M, Thadepalli H.
    Chemotherapy; 1985 Feb; 31(3):173-7. PubMed ID: 3996086
    [Abstract] [Full Text] [Related]

  • 20. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL, Monroy E, García O, Vaca S.
    Rev Latinoam Microbiol; 1998 Feb; 40(3-4):128-34. PubMed ID: 10932741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.